The Blood-brain Barrier
Physiological Pharmacokinetic Models: Blood Flow-Limited Versus Diffusion-Limited Models
Physiological Barriers
Passive Diffusion: Overview and Kinetics
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Jan 10, 2026

A Human Blood-Brain Interface Model to Study Barrier Crossings by Pathogens or Medicines and Their Interactions with the Brain
Published on: April 9, 2019
Dimitrios Charemis1, Gregory Sivolapenko2, Maria Hadjinicolaou3
1School of Science and Technology, Hellenic Open University, Patras, Greece. charemis.dimitris@ac.eap.gr.
This study introduces a new physiological model using partial differential equations (PDEs) to simulate passive solute transport across the blood-brain barrier (BBB). The model accurately predicts spatial and temporal solute concentrations, aiding neurological drug development.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: